- Pathogen genomics
- Whole-genome and targeted sequencing for strain and lineage characterization, variant profiling, phylogenetic relationships and resistance-associated variants. Across timepoints, the same framework tracks how a pathogen population changes under treatment pressure.
- Microbiome profiling
- 16S for community composition, diversity and differential abundance. Shotgun metagenomics where the question needs functional potential, strain-level resolution or low-abundance populations. Sequencing depth is set by the question and the sample complexity, not by a default.
- Antimicrobial resistance
- Resistance determinants identified from shotgun data and, where a specific marker matters, monitored by targeted assays across the cohort.
- Host response
- Bulk RNA-seq for the transcriptional changes associated with infection, severity, progression or treatment response, with differential expression reported at gene and pathway level.
- Host and pathogen together
- Metatranscriptomics, where both responses have to be read from the same material, so the pathogen’s activity and the host’s reaction are measured on one sample rather than inferred from two.
- Proteomics
- Protein-level quantification by mass spectrometry, matched against the transcriptomic result. Transcript and protein levels diverge often enough that agreement between them is informative in itself.
- Integration with clinical context
- Molecular measurements set against severity, treatment, sampling timepoint, outcome and patient characteristics, which is what separates a signal associated with infection from one associated with how sick the patient already was.
- Signature discovery
- Molecular signatures associated with severity, progression, treatment response or failure. Where independent cohorts exist, candidates are tested on data that did not contribute to finding them.